García-Villarreal OA

Idioma: Ingles.
Referencias bibliográficas: 5
Paginas: 43-44
Archivo PDF: 464.38 Kb.

RESUMEN

     

REFERENCIAS (EN ESTE ARTÍCULO)

1. Alabbadi S, Stebbins A, Vemulapalli S, et al. Trends in case mix and outcomes after transcatheter aortic valve replacement in patients younger than 65 years: insights from the STS/ACC TVT Registry. J Am Coll Cardiol. 2026: S0735-1097(26)00072-0. doi: 10.1016/j.jacc.2026.01.011.

2. FDA expands TAVR indication to low-risk patients [Internet]. American College of Cardiology. [cited 2026 Mar 4]. Available in: https://www.acc.org/Membership/Sections-and-Councils/Interventional-Section/Section-Updates/2019/08/19/08/16/FDA-Expands-TAVR-Indication-to-Low-Risk-Patients

3. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695-1705. doi: 10.1056/NEJMoa1814052.

4. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706-1715. doi: 10.1056/NEJMoa1816885.

5. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932.